OLR1 and hematoma: Serum sLOX-1 levels were significantly increased in patients compared to healthy controls, and were independently correlated with GCS scores (ρ = −0.577, p < 0.001; t = −6.732, p < 0.001) and hematoma volumes (ρ = 0.540, p < 0.001; t = 7.136, p < 0.001).